A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

Letter

A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies

Authors

R Burgos-Vargas PubMed articles Google scholar articles
J Vázquez-Mellado PubMed articles Google scholar articles
C Pacheco-Tena PubMed articles Google scholar articles
A Hernández-Garduño PubMed articles Google scholar articles
M V Goycochea-Robles PubMed articles Google scholar articles

Correspondence to:
Professor R Burgos-Vargas, Dirección de Investigación, Hospital General de Mexico, Dr Balmis 148, México DF 06726;
burgosv{at}attglobal.net

Citation

Burgos-Vargas R, Vázquez-Mellado J, Pacheco-Tena C, et al

A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies

Annals of the Rheumatic Diseases 2002;61:941-942.

Publication history

Accepted April 16, 2002
First published October 1, 2002.

Online issue publication

April 13, 2016

Copyright information

Copyright 2002 by Annals of the Rheumatic Diseases